Professional Overview
Giselle Habeych is a key professional associated with New Century Health, now operating under the umbrella of Evolent Health. Her LinkedIn profile (https://linkedin.com/in/giselle-habeych) identifies her as a strategic figure within this organization, which specializes in transforming cancer care through data-driven oncology solutions. New Century Health’s integration into Evolent Health places Giselle within a company focused on value-based care, population health management, and innovative healthcare delivery models.
Role and Responsibilities
While the exact current title for Giselle at New Century Health is not explicitly provided, her LinkedIn presence and association with Evolent Health position her at a senior leadership or strategic role involving healthcare operations or business development within oncology care management. Her role likely entails interfacing with health systems, payers, and providers to implement data-centric clinical pathways and optimize patient outcomes in cancer treatment networks.
Company Context and Relevance
New Century Health is a recognized leader in oncology clinical pathway management and value-based care programs. As part of Evolent Health, the company reported significant growth driven by expanding partnerships with healthcare payers and providers focused on cost-effective and evidence-based oncology care. Evolent Health’s broader operating revenues registered approximately US $494 million in recent financial periods, reflecting robust demand for integrated care solutions. This context signals strategic priorities around data integration, care coordination, and value measurement—areas likely central to Giselle’s responsibilities.
Professional Interests and Expertise
Giselle’s LinkedIn presence suggests deep expertise in healthcare strategy, oncology-focused solutions, and value-based contracting. Her professional focus includes leveraging clinical data to improve cancer care delivery while balancing cost containment and quality metrics. These competencies are critical as New Century Health targets oncology care networks seeking to enhance adherence to approved treatment pathways and optimize clinical and economic outcomes.
Actionable Insights
Given Giselle Habeych’s engagement with a rapidly scaling healthcare company specializing in oncology clinical pathways and value-based care, conversations and proposals aligned with data analytics, care coordination platforms, clinical decision support tools, and payer-provider collaboration frameworks would align closely with her operational priorities. Understanding the evolving regulatory and reimbursement landscape surrounding oncology pathways will be instrumental in addressing her objectives. Moreover, emphasizing scalable solutions capable of integrating with existing EHR systems and demonstrating measurable impact on outcomes and cost reduction will be particularly relevant.
This report consolidates the available data on Giselle Habeych within the context of New Century Health/Evolent Health, prioritizing insights most pertinent to her professional influence and the company’s strategic direction in oncology care innovation.
